GlassScriptPhysician profile
Kayle Sessions
NPI 1679131890
$1,243.91
in general payments reported to CMS, 2019-2025
18 companies · $418 in 2025
The $418 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $331 · 2023: $111 · 2024: $383 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $913.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $217.06 | 2022 | |
| Mayne Pharma Commercial LLC | $187.61 | 2023-2025 | |
| Coopersurgical, INC. | $155.91 | 2024-2025 | Paragard T 380a |
| Abbvie INC. | $136.67 | 2022-2024 | |
| Biogen, INC. | $136.64 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $62.39 | 2024-2025 | Veozah |
| Organon LLC | $48.13 | 2024 | |
| Exeltis, USA INC. | $45.89 | 2024-2025 | Slynd |
| Shield Therapeutics INC | $45.42 | 2025 | |
| Intuitive Surgical, INC. | $41.58 | 2023 | Da Vinci Surgical System |
| Sumitomo Pharma America, INC. | $33.40 | 2024 | Myfembree |
| Hologic Sales and Service, LLC | $30.13 | 2024 | Myosure Tissue Removal Device |
| Boston Scientific Corporation | $25.09 | 2025 | Axonics |
| Exact Sciences Corporation | $20.57 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $17.20 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $15.07 | 2025 | |
| Millicent US INC | $14.24 | 2025 | Femlyv |
| Aspira Women'S Health INC | $10.91 | 2024 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kayle Sessions listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.